Trial record 1 of 1 for:    shrinc
Previous Study | Return to List | Next Study

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

This study has been completed.
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston Identifier:
First received: January 21, 2009
Last updated: October 1, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)